Klaus Klumpp
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$9.0MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $9.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 19, 2021 | NIH | SBIR Phase II Advancing a novel potent double anti-HCV nucleoside analog combination treatment for the OUD population to the clinic | $995K | Riboscience LLC |
| Aug 6, 2020 | NIH | SBIR Phase II Advancing a novel potent double anti-HCV nucleoside analog combination treatment for the OUD population to the clinic | $995K | Riboscience LLC |
| Sep 9, 2019 | NIH | SBIR Phase II Advancing a novel potent double anti-HCV nucleoside analog combination treatment for the OUD population to the clinic | $995K | Riboscience LLC |
| Jul 10, 2019 | NIH | SBIR Phase II Advancing a novel potent Zika virus specific nucleoside analog to the clinic | $995K | Riboscience LLC |
| Jul 19, 2018 | NIH | SBIR Phase II Advancing a novel potent Zika virus specific nucleoside analog to the clinic | $995K | Riboscience LLC |
| Aug 18, 2017 | NIH | SBIR Phase II Advancing a novel potent Zika virus specific nucleoside analog to the clinic | $994K | Riboscience LLC |
| Aug 18, 2017 | NIH | SBIR Phase II Advancing a novel potent Zika virus specific nucleoside analog to the clinic | $3.0M | Riboscience LLC |
1 patents as inventor
- US Riboscience LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#90
Awards as PI#250
Patents#273
Companies
- Riboscience LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.